Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

IXHL

Incannex Healthcare (IXHL)

Incannex Healthcare Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IXHL
DateTimeSourceHeadlineSymbolCompany
12/12/202408:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
09/12/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:IXHLIncannex Healthcare Ltd
07/12/202408:23Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:IXHLIncannex Healthcare Ltd
27/11/202408:06Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:IXHLIncannex Healthcare Ltd
15/11/202408:05GlobeNewswire Inc.Incannex Healthcare Inc. Reports Fiscal First Quarter 2025 Financial Results and Business UpdatesNASDAQ:IXHLIncannex Healthcare Ltd
12/11/202422:07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:IXHLIncannex Healthcare Ltd
12/11/202422:04Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:IXHLIncannex Healthcare Ltd
07/11/202408:19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IXHLIncannex Healthcare Ltd
07/11/202408:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:IXHLIncannex Healthcare Ltd
01/11/202407:10Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:IXHLIncannex Healthcare Ltd
25/10/202407:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IXHLIncannex Healthcare Ltd
25/10/202407:48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IXHLIncannex Healthcare Ltd
24/10/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
24/10/202422:30GlobeNewswire Inc.Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical OfficerNASDAQ:IXHLIncannex Healthcare Ltd
24/10/202422:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
22/10/202407:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
16/10/202406:54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
01/10/202406:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
01/10/202406:01GlobeNewswire Inc.Incannex Healthcare Inc. Reports Fiscal Full Year 2024 Financial Results and Business UpdatesNASDAQ:IXHLIncannex Healthcare Ltd
30/09/202421:30Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:IXHLIncannex Healthcare Ltd
10/09/202422:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
10/09/202422:00GlobeNewswire Inc.Incannex Healthcare Announces Strategic Financing for up to $60 Million with Arena InvestorsNASDAQ:IXHLIncannex Healthcare Ltd
10/09/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
10/09/202421:00Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:IXHLIncannex Healthcare Ltd
05/08/202421:30GlobeNewswire Inc.FDA Review of PsiGAD2 IND complete; clinical trial for Psilocybin Assisted Psychotherapy in Patients with Generalised Anxiety Disorder to ProceedNASDAQ:IXHLIncannex Healthcare Ltd
30/07/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
30/07/202421:30GlobeNewswire Inc.Dosing completed in 115 participant bioavailability/bioequivalence clinical trial for proprietary sleep apnea drug candidate IHL-42XNASDAQ:IXHLIncannex Healthcare Ltd
30/05/202422:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IXHLIncannex Healthcare Ltd
30/05/202421:30GlobeNewswire Inc.Patient dosing commenced in RePOSA Phase 2/3 Clinical Trial Protocol to Assess IHL-42X Drug in Patients with Obstructive Sleep ApneaNASDAQ:IXHLIncannex Healthcare Ltd
07/05/202421:30GlobeNewswire Inc.Incannex Complete Successful Pre-IND Meeting with the FDA for CannQuit-O for treatment of opioid use disorderNASDAQ:IXHLIncannex Healthcare Ltd
 Showing the most relevant articles for your search:NASDAQ:IXHL

Your Recent History

Delayed Upgrade Clock